
Metagenomic Sequencing Revolutionizes Pathogen Diagnosis Across Medical Fields
Researchers at UC San Francisco have developed a metagenomic next-generation sequencing (mNGS) test that can rapidly identify a wide range of pathogens, including viruses, bacteria, fungi, and parasites. This test, which analyzes all nucleic acids in a sample, has proven effective in diagnosing neurological infections and could be crucial for early detection of pandemic threats. The mNGS test, now automated for faster results, has been shown to accurately identify pathogens in cerebrospinal and respiratory fluids, and has received FDA breakthrough device designation.




